Signosis is a molecular tool company that is focused on developing innovative and unique products for biomarker discovery and analysis in the areas of life science research, clinical application and drug discovery. Our mission is to become a worldwide provider with a broad spectrum of more sensitive, cost-effective, rapid assay products to target biomarkers such as disease-related proteins, mRNAs, microRNAs, epigenetic variations, and SNP, with emphasis in a number of diseases including cancers, diabetes/obesity, and cardiovascular diseases